Morgan J D, Eady J L
Department of Orthopaedic Surgery, University of South Carolina School of Medicine, Columbia, USA.
J South Orthop Assoc. 1999 Winter;8(4):275-84.
Conventional wisdom suggests that giant cell tumor (GCT) does not occur in the skeletally immature individual; however, we believe that GCTs of bone, though rare, do occur in children. We are reporting the occurrence of GCT of bone in three patients who were skeletally immature at the time of their initial presentation. In our review of the reports since 1954 that document this condition, we were also able to find a total of 318 patients, of whom 130 were skeletally immature at the time of their tumor presentation. From the data compiled, we found a 7.5% incidence of GCT of bone in skeletally immature individuals at a mean age of 10.5 years. Based on our review and the experience with our three patients, we believe the diagnosis of GCT of bone should be considered in the differential diagnosis of a destructive lesion of bone in skeletally immature individuals. Giant cell tumor in the skeletally immature is being reported here to better define its incidence and increase awareness of its occurrence. Management options will also be discussed.
传统观点认为,巨细胞瘤(GCT)不会发生在骨骼未成熟的个体中;然而,我们认为骨巨细胞瘤虽然罕见,但确实会发生在儿童身上。我们报告了3例在初次就诊时骨骼未成熟的骨巨细胞瘤患者。在我们回顾自1954年以来记录这种情况的报告时,我们还总共找到了318例患者,其中130例在肿瘤出现时骨骼未成熟。根据汇编的数据,我们发现骨骼未成熟个体中骨巨细胞瘤的发病率为7.5%,平均年龄为10.5岁。基于我们的回顾以及对3例患者的经验,我们认为在骨骼未成熟个体的骨破坏性病变的鉴别诊断中应考虑骨巨细胞瘤的诊断。本文报告骨骼未成熟个体中的巨细胞瘤,以更好地确定其发病率并提高对其发生的认识。还将讨论治疗选择。